ADMA Biologics, Inc. (ADMA)
8.53
+0.03
(+0.35%)
USD |
NASDAQ |
May 15, 09:31
ADMA Biologics Shareholders Equity (Quarterly) : 390.32M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Inovio Pharmaceuticals, Inc. | 6.068M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| AnaptysBio, Inc. | 12.75M |
| Kodiak Sciences, Inc. | 112.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 665.18M |
| Total Liabilities (Quarterly) | 274.86M |
| Debt to Equity Ratio | 0.5237 |
| Current Ratio | 6.951 |
| Net Debt Paydown Yield | -1.17% |